癌症基因组变化和微环境特征编码与疾病结果的协同相互作用
Masroor Bayati1, Zoe P Klein1, Alexander T Bahcheli1
1University of Toronto, Canada.
Molecular cancer research : MCR
|September 3, 2025
概括
我们确定了34种免疫基因相互作用 (IGXs) 能够将癌症驱动因素和免疫细胞与13种癌症患者的生存联系起来. 通过整合基因组和免疫数据,这些发现揭示了预后生物标志物和治疗点.
科学领域:
- 癌症学
- 免疫学
- 基因组学
背景情况:
- 癌症进展受到体内基因组变化和瘤免疫微环境 (TME) 的影响.
- 在塑造瘤进化和临床结果方面,基因组驱动因素和TME特征之间的相互作用尚未完全理解.
研究的目的:
- 开发一个整合多组数据的框架,以确定与临床结果相关的癌症驱动因素和TME特征之间的相互作用.
- 发现具有预后潜力的新型免疫基因相互作用 (IGX).
主要方法:
- 开发了多经济学分析框架PACIFIC.
- 系统地整合了基因癌症驱动因素和免疫细胞透概况.
- 分析了26种癌症中的8500个原发性瘤样本.
主要成果:
- 在13种癌症中确定了34个IGX,将特定的基因组变化和免疫细胞水平与患者的存活率联系起来.
- 发现IGX可以定义具有独特免疫性和免疫治疗向基因表达的瘤子集.
- 在光线A乳腺癌中观察到IGX (MEN1缺失和低中性粒细胞),与无进展生存率较差相关.
结论:
- 为了确定临床相关的IGX,PACIFIC框架有效地整合了多种OMIC和临床数据.
- 发现了预测性IGX,为机理学研究,生物标志物开发和治疗向提供假设.
- 癌症驱动因素和TME特征的同时发生模式显示出具有预后价值的协同作用.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


